Clinical Trial Update: Controlled Study of ONO-2506PO in Patients With Parkinson's Disease in Japan [Phase 2]

View source ↗

Summary

A Phase 2 controlled study of ONO-2506PO in Parkinson's disease patients in Japan has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• ONO-2506PO

Snippet

Sponsor: Ono Pharmaceutical Co., Ltd. | Conditions: Parkinson's Disease | Phase 2 | Status: COMPLETED